AUS
NZ
UK
CA
USA
IND
Why Are These ASX Bluechip Stocks So Widely Tracked?
Explore major ASX bluechip companies across mining, banking, healthcare, financial services, retail, and consumer staples within Australia’s key market benchmarks.
- June 02, 2026 11:49 AM AEST
- Sam
Three ASX Dividend Stocks Standing Out in June
Computershare, Helloworld Travel and QBE Insurance remain among the ASX dividend stocks attracting attention due to their distributions, business strength and sector exposure.
- June 02, 2026 11:47 AM AEST
- Sam
Federal Court Penalty Puts Westpac Under Spotlight Amid Compliance Concerns
A Federal Court penalty against Westpac highlights growing regulatory expectations around customer outcomes, operational controls, and compliance standards.
- June 02, 2026 11:43 AM AEST
- Sam
Cochlear’s Innovation Focus Remains in Spotlight Despite Operational Challenges
Highlights,Cochlear continues advancing MRI-compatible hearing implant technology.,Hospital capacity constraints and currency headwinds have weighed on recent performance.,Long-term growth outlook remains tied to expanding demand for implantable hearing s...
- June 02, 2026 11:42 AM AEST
- Sam
Hidden Opportunities? Three ASX Stocks Drawing Attention in June
Engineering services, healthcare distribution and infrastructure networks remain key themes supporting investor interest in EVZ, Sigma Healthcare and Service Stream.
- June 02, 2026 11:40 AM AEST
- Sam
ASX Penny Stocks With Strong Financial Foundations Drawing Attention
Several smaller ASX-listed companies with market capitalisations above the traditional penny stock range continue attracting attention due to strong financial positions and business development initiatives.
- June 02, 2026 11:34 AM AEST
- Sam
Navigator Global's New Share Issue Raises Questions About Growth Plans
Navigator Global has applied to list approximately new shares on the ASX. The move expands the company’s quoted capital base, improves liquidity
- June 02, 2026 11:26 AM AEST
- Sam
Why Paradigm’s Massive New Share Issue Is Drawing Attention
Paradigm Biopharmaceuticals has applied to quote more than forty-three million new shares on the ASX. The move expands tradable securities, enhances liquidity
- June 02, 2026 11:24 AM AEST
- Sam
Atlas Arteria Pushes Back Against IFM Bid: What Happens Next?
Atlas Arteria has recommended shareholders reject IFM's takeover proposal, arguing the offer fails to reflect the value of its international toll road assets. The company remains focused on long-term value creation while investors await potential developm
- June 02, 2026 11:22 AM AEST
- Sam
Why Are These ASX AI Stocks Attracting Attention?
Explore Australia's AI stock landscape through BrainChip Holdings, WiseTech Global, Appen, NEXTDC, and Megaport across hardware, software, and digital infrastructure segments.
- June 02, 2026 11:22 AM AEST
- Sam